Dachaigh › Myasthenia Gravis
Sgrùdaidhean clionaigeach Myasthenia Gravis a’ fastadh anns na SA
Tha 45 sgrùdaidhean airson Myasthenia Gravis a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Tampa, FL12 sgrùdaidhean
- Houston, TX11 sgrùdadh
- Durham, NC10 sgrùdaidhean
- Boca Raton, FL10 sgrùdaidhean
- Columbus, OH8 sgrùdaidhean
- Miami, FL7 sgrùdaidhean
- New York City, NY7 sgrùdaidhean
- Milwaukee, WI7 sgrùdaidhean
- St. Louis, MO7 sgrùdaidhean
- Boston, MA6 sgrùdaidhean
- Washington, DC6 sgrùdaidhean
- San Francisco, CA6 sgrùdaidhean
- Orange, CA6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Columbia, MO6 sgrùdaidhean
- Portland, OR6 sgrùdaidhean
- Kansas City, KS6 sgrùdaidhean
- Austin, TX6 sgrùdaidhean
- Chattanooga, TN6 sgrùdaidhean
- Jacksonville, FL6 sgrùdaidhean
- Dallas, TX6 sgrùdaidhean
- Detroit, MI6 sgrùdaidhean
- Charleston, SC6 sgrùdaidhean
- Aurora, CO5 sgrùdaidhean
- Lexington, KY5 sgrùdaidhean
- Scottsdale, AZ5 sgrùdaidhean
- Port Charlotte, FL5 sgrùdaidhean
- Cincinnati, OH5 sgrùdaidhean
- Mountain View, CA4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Chicago, IL4 sgrùdaidhean
- Amherst, NY4 sgrùdaidhean
- New Haven, CT4 sgrùdaidhean
- Augusta, GA4 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
- Raleigh, NC3 sgrùdaidhean
- Knoxville, TN3 sgrùdaidhean
- Phoenix, AZ3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- Lansing, MI3 sgrùdaidhean
Le stàit
- Arizona7 sgrùdaidhean
- California20 sgrùdaidhean
- Colorado8 sgrùdaidhean
- Connecticut6 sgrùdaidhean
- Florida22 sgrùdaidhean
- Georgia4 sgrùdaidhean
- Illinois12 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Kansas7 sgrùdaidhean
- Kentucky6 sgrùdaidhean
- Massachusetts11 sgrùdadh
- Michigan12 sgrùdaidhean
- Minnesota3 sgrùdaidhean
- Missouri7 sgrùdaidhean
- Nevada3 sgrùdaidhean
- New Jersey3 sgrùdaidhean
- New York13 sgrùdaidhean
- North Carolina14 sgrùdaidhean
- Ohio13 sgrùdaidhean
- Oregon8 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Sgìre Cholumbia6 sgrùdaidhean
- South Carolina7 sgrùdaidhean
- Tennessee10 sgrùdaidhean
- Texas18 sgrùdaidhean
- Virginia3 sgrùdaidhean
- Washington3 sgrùdaidhean
- Wisconsin7 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
A’ fastadhÌre 2
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06987539Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07787247Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07217587A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07463521A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07647510ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07284420A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07465289A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07501702A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06680037Zilucoplan for Severe gMG Exacerbations
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06414954AXIS MG Patient Registry
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07761026A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07304154RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT06359041Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 64 · Banairean · Air ùrachadh 11 Lùna 2026 · NCT06940323MuSK Myasthenia 1000 Study
A’ fastadhSgrùdadh amharc
Aoisean 7 gu 99 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06259071Study of Aritinercept in Patients With Generalized Myasthenia Gravis
A’ fastadhÌre 1/2
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
A’ fastadhÌre 2/3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A’ fastadhÌre 2/3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06193889A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT04951622Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.